| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 4.53B | 5.00B | 4.89B | 4.58B | 4.29B |
| Gross Profit | 1.66B | 1.76B | 1.73B | 1.62B | 1.48B |
| EBITDA | 927.10M | 819.03M | 855.15M | 889.85M | 1.04B |
| Net Income | 564.70M | 493.20M | 540.71M | 549.50M | 688.37M |
Balance Sheet | |||||
| Total Assets | 6.25B | 6.39B | 6.43B | 6.39B | 6.51B |
| Cash, Cash Equivalents and Short-Term Investments | 325.00M | 514.33M | 742.53M | 817.98M | 965.59M |
| Total Debt | 826.40M | 789.74M | 807.31M | 826.83M | 881.17M |
| Total Liabilities | 2.78B | 2.89B | 2.86B | 2.83B | 2.88B |
| Stockholders Equity | 3.43B | 3.46B | 3.52B | 3.52B | 3.59B |
Cash Flow | |||||
| Free Cash Flow | 645.14M | 618.93M | 698.27M | 529.50M | 715.37M |
| Operating Cash Flow | 749.10M | 724.43M | 822.63M | 756.72M | 925.81M |
| Investing Cash Flow | -2.06M | -127.41M | -224.50M | -262.50M | -329.00M |
| Financing Cash Flow | -768.12M | -771.02M | -651.43M | -629.90M | -870.93M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | $13.22B | 26.95 | 10.64% | ― | 4.21% | -0.63% | |
70 Outperform | $7.89B | 14.38 | 16.45% | 2.57% | -9.43% | 19.14% | |
68 Neutral | $5.16B | 27.33 | 15.52% | ― | 23.16% | 27.38% | |
62 Neutral | $6.26B | -87.29 | -6.10% | ― | 32.81% | -36.32% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |
On February 3, 2026, Amdocs reported results for the first quarter of fiscal 2026, covering the three months ended December 31, 2025, posting revenue of $1.16 billion, up 4.1% year-on-year as reported and slightly above the midpoint of guidance, with Europe growing 17.1%, managed services comprising about 65% of sales, and both GAAP and non-GAAP EPS topping guidance on the back of a lower effective tax rate and improved profitability. The company highlighted a stronger operating margin, robust free cash flow of $188 million, $146 million in share repurchases and a $4.25 billion twelve‑month backlog, while reinforcing its fiscal 2026 revenue growth outlook in constant currency and signaling a strategic push into generative AI and broader telecom transformation through a new multi-year strategic agreement with T-Mobile USA, expanded engagements with Vodafone Germany and other European customers, the completed acquisition of Matrixx Software, and the launch of aOS, an agentic operating system designed to position Amdocs as a key technology partner for operators pursuing AI, cloud migration and fiber rollout initiatives.
The most recent analyst rating on (DOX) stock is a Buy with a $92.00 price target. To see the full list of analyst forecasts on Amdocs stock, see the DOX Stock Forecast page.
On February 3, 2026, Amdocs announced that long-serving CEO Shuky Sheffer will retire and hand leadership to Shimie Hortig, the current Group President of the Americas, effective March 31, 2026. The carefully planned succession underscores Amdocs’ intent to preserve strategic continuity as it deepens its cloud and generative AI capabilities for telecom clients, reinforcing stakeholder confidence in its positioning for the next phase of industry transformation.
The most recent analyst rating on (DOX) stock is a Buy with a $92.00 price target. To see the full list of analyst forecasts on Amdocs stock, see the DOX Stock Forecast page.
At its Annual General Meeting of Shareholders held on January 30, 2026, Amdocs Limited reported that investors re-elected all ten board nominees for one-year terms, signaling continued support for the company’s existing leadership and strategic direction. Shareholders also approved an amendment to the 2023 Employee Share Purchase Plan to reserve an additional 2.2 million ordinary shares, endorsed an increase in the quarterly cash dividend from $0.527 to $0.569 per share, approved the consolidated financial statements for the fiscal year ended September 30, 2025, and ratified Ernst & Young LLP as auditor for the fiscal year ending September 30, 2026, collectively reinforcing Amdocs’ capital return policy, employee equity participation, and governance framework.
The most recent analyst rating on (DOX) stock is a Buy with a $97.00 price target. To see the full list of analyst forecasts on Amdocs stock, see the DOX Stock Forecast page.
On December 16, 2025, Amdocs Limited released its annual report for the fiscal year ending September 30, 2025. The report, which was issued as part of a Form 6-K filing, provides insights into the company’s financial performance and strategic initiatives over the past year. This release is significant for stakeholders as it offers a comprehensive overview of Amdocs’ operational achievements and future outlook, reinforcing its position in the competitive software and services market.
The most recent analyst rating on (DOX) stock is a Buy with a $97.00 price target. To see the full list of analyst forecasts on Amdocs stock, see the DOX Stock Forecast page.
Amdocs Limited has announced its upcoming annual general meeting of shareholders, scheduled for January 30, 2026, in Jersey City, NJ. Key agenda items include the election of ten directors, an amendment to the Employee Share Purchase Plan to increase share issuance by 2.2 million shares, an increase in the quarterly dividend rate, approval of the fiscal year 2025 financial statements, and the ratification of Ernst & Young LLP as the independent accounting firm for fiscal year 2026. These proposals reflect Amdocs’ ongoing strategic initiatives to enhance shareholder value and ensure robust corporate governance.
The most recent analyst rating on (DOX) stock is a Buy with a $97.00 price target. To see the full list of analyst forecasts on Amdocs stock, see the DOX Stock Forecast page.
On November 11, 2025, Amdocs Limited announced its financial results for the fourth quarter and full fiscal year 2025, reporting a revenue of $4.53 billion, a decrease of 9.4% year-over-year due to the phase-out of certain business activities. Despite this, the company achieved a record managed services revenue and improved profitability, driven by operational efficiencies and a focus on high-margin activities. Amdocs also highlighted strong sales momentum and significant international expansion, securing major contracts with companies like TELUS, Lumen Technologies, and British Telecom. The company is increasing its investment in generative AI to unlock new growth opportunities, with a strategic focus on modernizing IT operations and enhancing customer experiences. Looking forward, Amdocs expects revenue growth in the range of 1.7% to 5.7% for fiscal year 2026.
The most recent analyst rating on (DOX) stock is a Buy with a $97.00 price target. To see the full list of analyst forecasts on Amdocs stock, see the DOX Stock Forecast page.